Literature DB >> 16133096

Discrete choice experiments in health economics: distinguishing between the method and its application.

Emily Lancsar1, Cam Donaldson.   

Abstract

Bryan and Dolan have offered a critique of the use of discrete choice experiments in health economics. Their call for more open debate on "the relative strengths and limitations of the DCE method, particularly when applied in health settings" is warranted. However, their paper has only added to part of this debate in that it focuses on the application of choice experiments in the health sector but says little on the strengths and limitations of the DCE method in general. We argue that while the criticisms posed by Bryan and Dolan rightly challenge the manner in which DCEs have been applied in health economics, such criticism does not challenge the theoretical/methodological basis of DCEs per se.

Entities:  

Mesh:

Year:  2005        PMID: 16133096     DOI: 10.1007/s10198-005-0304-3

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  4 in total

1.  Conducting discrete choice experiments to inform healthcare decision making: a user's guide.

Authors:  Emily Lancsar; Jordan Louviere
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  The Value of Clinical Needs Assessments for Point-of-Care Diagnostics.

Authors:  Bernhard H Weigl; Charlotte A Gaydos; Gerald Kost; Fred R Beyette; Stephanie Sabourin; Anne Rompalo; Tala de Los Santos; Jason T McMullan; John Haller
Journal:  Point Care       Date:  2012-06

3.  Preferences heterogeneity of health care utilization of community residents in China: a stated preference discrete choice experiment.

Authors:  Ming-Zhu Jiang; Qiang Fu; Ju-Yang Xiong; Xiang-Lin Li; Er-Ping Jia; Ying-Ying Peng; Xiao Shen
Journal:  BMC Health Serv Res       Date:  2020-05-18       Impact factor: 2.655

4.  Towards Personalising the Use of Biologics in Rheumatoid Arthritis: A Discrete Choice Experiment.

Authors:  Caroline M Vass; Anne Barton; Katherine Payne
Journal:  Patient       Date:  2021-06-18       Impact factor: 3.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.